Coya Therapeutics, Inc.
Industry
- Pharmaceuticals
- Biotechnology
- Gene Therapy, Cell Therapy
- Large Molecule
Other Names/Subsidiaries
- Nicoya Health
- Nicoya Lifesciences
Latest on Coya Therapeutics, Inc.
Neurological disorders account for roughly 45% of rare diseases; and 85% of rare and ultra-rare disease trace back to a single gene defect. Given this, the potential for regenerative therapies to bene
Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Bristol, VantAI Pair Technologies In Pr
The year gone by saw India Pharma Inc scale new peaks in terms of cutting-edge R&D advances but there were perilous valleys as well as quality issues hit hard, threatening to eclipse the industry’s re
Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Coya And Dr Reddy’s Ink Deal For C